Net Cash Provided by (Used in) Operating Activities |
-33.3M |
USD |
-117% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
4.97M |
USD |
-87.8% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-28.3M |
USD |
-211% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
15.6M |
USD |
-87.4% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
224K |
USD |
-77.1% |
Q2 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
6.13M |
USD |
+163% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
3.76M |
USD |
+213% |
Q2 2025 |
Q2 2025 |
Current Income Tax Expense (Benefit) |
81K |
USD |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
1.08B |
USD |
+14.4% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
3.61M |
USD |
+362% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |